GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Piotroski F-Score

Decision Diagnostics (Decision Diagnostics) Piotroski F-Score : 0 (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Decision Diagnostics has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Decision Diagnostics's Piotroski F-Score or its related term are showing as below:


Decision Diagnostics Piotroski F-Score Historical Data

The historical data trend for Decision Diagnostics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Piotroski F-Score Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 - - 5.00 3.00

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 3.00 N/A N/A N/A

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep21) TTM:Last Year (Sep20) TTM:
Net Income was -6.914 + -0.972 + -0.302 + -0.555 = $-8.74 Mil.
Cash Flow from Operations was 0.049 + -0.508 + -0.518 + -0.06 = $-1.04 Mil.
Revenue was 0.522 + 0.538 + 0.552 + 0.519 = $2.13 Mil.
Gross Profit was 0.14 + 0.108 + 0.135 + 0.115 = $0.50 Mil.
Average Total Assets from the begining of this year (Sep20)
to the end of this year (Sep21) was
(6.044 + 5.654 + 5.47 + 5.332 + 5.343) / 5 = $5.5686 Mil.
Total Assets at the begining of this year (Sep20) was $6.04 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $1.27 Mil.
Total Current Liabilities was $5.40 Mil.
Net Income was -2.138 + -0.768 + -17.215 + -4.735 = $-24.86 Mil.

Revenue was 0.733 + 0.574 + 0.363 + 0.521 = $2.19 Mil.
Gross Profit was 0.428 + 0.198 + 0.1 + 0.096 = $0.82 Mil.
Average Total Assets from the begining of last year (Sep19)
to the end of last year (Sep20) was
(0 + 5.305 + 6.271 + 5.804 + 6.044) / 5 = $5.856 Mil.
Total Assets at the begining of last year (Sep19) was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $2.00 Mil.
Total Current Liabilities was $5.79 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Decision Diagnostics's current Net Income (TTM) was -8.74. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Decision Diagnostics's current Cash Flow from Operations (TTM) was -1.04. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep20)
=-8.743/6.044
=-1.44655857

ROA (Last Year)=Net Income/Total Assets (Sep19)
=-24.856/0
=

Decision Diagnostics's return on assets of this year was -1.44655857. Decision Diagnostics's return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Decision Diagnostics's current Net Income (TTM) was -8.74. Decision Diagnostics's current Cash Flow from Operations (TTM) was -1.04. ==> -1.04 > -8.74 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep20 to Sep21
=0/5.5686
=0

Gearing (Last Year: Sep20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep19 to Sep20
=0/5.856
=0

Decision Diagnostics's gearing of this year was 0. Decision Diagnostics's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep21)=Total Current Assets/Total Current Liabilities
=1.274/5.395
=0.23614458

Current Ratio (Last Year: Sep20)=Total Current Assets/Total Current Liabilities
=1.998/5.788
=0.34519696

Decision Diagnostics's current ratio of this year was 0.23614458. Decision Diagnostics's current ratio of last year was 0.34519696. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Decision Diagnostics's number of shares in issue this year was 357.871. Decision Diagnostics's number of shares in issue last year was 304.791. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.498/2.131
=0.2336931

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.822/2.191
=0.37517115

Decision Diagnostics's gross margin of this year was 0.2336931. Decision Diagnostics's gross margin of last year was 0.37517115. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep20)
=2.131/6.044
=0.35258107

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep19)
=2.191/0
=

Decision Diagnostics's asset turnover of this year was 0.35258107. Decision Diagnostics's asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Decision Diagnostics has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Decision Diagnostics  (OTCPK:DECN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Decision Diagnostics Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus